SEC Form 4
Edesa Biotech, Inc. Common Shares (EDSA) insider trading
In the 12 months to Oct 26, 2026, 2 EDSA insiders reported open-market purchases of $233.1K across 7 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $233.1K
- 7 filings
Who traded EDSA, and when
- Purchase
EDSA daily close from Oct 27, 2025 to Oct 26, 2026, between $0.80 and $18.28, last $2.61. 0 sale and 7 purchase filings by 2 insiders, marked at their filing dates. Pardeep Nijhawan, Chief Executive Officer: bought $229.9K across 6 filings, first filed Mar 2, 2026, last Mar 10, 2026. Michael J. Brooks, President: bought $3.1K across 1 filing, first filed Mar 11, 2026, last Mar 11, 2026.
Largest mark · tap a row for others
Pardeep Nijhawan · Chief Executive Officer
Filing 1 of 5 within a week · $223,315 total
Purchase $99,176
50,571 shares at $1.96 avg
Filed Mar 2, 2026 · traded Feb 26
Close on filing date $2.28
Pardeep Nijhawan · Chief Executive Officer
Chief Executive Officer
$229.9K boughtMichael J. Brooks · President
President
$3.1K boughtOpen-market trades
7 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Pardeep Nijhawan | Chief Executive Officer | — | $229.9K | 6 | — | |
| Michael J. Brooks | President | — | $3.1K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Michael J. Brooks President | Purchase | 2,000 | $1.57 | $3.1K | 226,870 | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 1,000 | $6.60 | $6.6K | 628,813 | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 10,000 | $3.90 | $39.0K | 402,702 | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 10,000 | $4.26 | $42.6K | 392,702 | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 10,000 | $3.63 | $36.3K | 382,702 | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 3,000 | $2.09 | $6.3K | Multiple accounts | |
traded | Pardeep Nijhawan Chief Executive Officer | Purchase | 50,571 | $1.96 | $99.2K | Multiple accounts |
GET /stocks/filings/vX/form-4?tickers=EDSA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"EDSA"
],
"issuer_cik": "0001540159",
"owner_cik": "0001779126",
"accession_number": "0001171843-26-001490",
"form_type": "4",
"filing_date": "2026-03-11",
"period_of_report": "2026-02-26",
"issuer_name": "Edesa Biotech, Inc.",
"issuer_trading_symbol": "EDSA",
"owner_name": "Brooks Michael J",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-02-26",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2000,
"transaction_price_per_share": 1.57,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 226870,
"transaction_value": 3140,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"EDSA"
],
"issuer_cik": "0001540159",
"owner_cik": "0001777962",
"accession_number": "0001171843-26-001463",
"form_type": "4",
"filing_date": "2026-03-10",
"period_of_report": "2026-03-10",
"issuer_name": "Edesa Biotech, Inc.",
"issuer_trading_symbol": "EDSA",
"owner_name": "Nijhawan Pardeep",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-10",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 1000,
"transaction_price_per_share": 6.5989,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 628813,
"transaction_value": 6598.900000000001,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 23 records
- Grants and awards23 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Edesa Biotech, Inc. Common Shares' CEO sold stock?
No. Pardeep Nijhawan (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is EDSA’s insider data?
These are EDSA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track EDSA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for EDSA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.